Although Wang et al. in 2017 suggested only part of patients with positive reaction to TFE3-IHC were eventually pathologically diagnosed with Xp11.2 tRCC by FISH assay [80]. This evidence concerns the gene TFE3 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.